Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
The return on assets (ROA) is N/A as of Tuesday, October 6, 2026.
RETURN ON ASSETS (ROA)
N/A
Market Cap
$132.03M
Return on Assets (ROA)
-35.50%
TTM Avg
-18.07%
3Y Avg
-62.20%
5Y Avg
-134.72%
Market Cap
$131.21M
Return on Assets (ROA)
-6.07%
TTM Avg
-5.08%
3Y Avg
-4.92%
5Y Avg
-1.70%
Market Cap
$130.79M
Return on Assets (ROA)
-73.85%
TTM Avg
-21.75%
3Y Avg
-19.65%
5Y Avg
-19.48%
Market Cap
$136.57M
Return on Assets (ROA)
10.55%
TTM Avg
-7.15%
3Y Avg
-30.40%
5Y Avg
-23.45%
Market Cap
$136.67M
Return on Assets (ROA)
-33.22%
TTM Avg
-27.55%
3Y Avg
-27.55%
5Y Avg
-27.55%
Market Cap
$137.80M
Return on Assets (ROA)
-6.51%
TTM Avg
-15.82%
3Y Avg
-25.09%
5Y Avg
-19.08%
Market Cap
$127.98M
Return on Assets (ROA)
-161.55%
TTM Avg
-68.10%
3Y Avg
-58.95%
5Y Avg
-64.88%
Market Cap
$139.04M
Return on Assets (ROA)
-28.35%
TTM Avg
-69.97%
3Y Avg
-58.34%
5Y Avg
-49.63%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $133.45M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | -35.50% | -18.07% | -62.20% | -134.72% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | -6.07% | -5.08% | -4.92% | -1.70% |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | -73.85% | -21.75% | -19.65% | -19.48% |
| Organigram Global Inc. (OGI)vs › | $136.57M | 10.55% | -7.15% | -30.40% | -23.45% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | -33.22% | -27.55% | -27.55% | -27.55% |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.80M | -6.51% | -15.82% | -25.09% | -19.08% |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | -161.55% | -68.10% | -58.95% | -64.88% |
| Immuneering Corporation (IMRX)vs › | $139.04M | -28.35% | -69.97% | -58.34% | -49.63% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -36.33% | -27.39% | -256.74% | -207.88% |
ROA
N/A
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
